PALI

Palisade Bio, Inc. - Common Stock (PALI)

About Palisade Bio, Inc. - Common Stock (PALI)

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies for inflammatory bowel diseases. Its programs include PALI-2108 and LB1148. The company was founded on September 6, 2011 and is headquartered in Denver, CO.

Details

Daily high
$1.97
Daily low
$1.82
Price at open
$1.90
52 Week High
$2.86
52 Week Low
$0.53
Market cap
324.6M
Dividend yield
0.00%
Volume
2.1M
Avg. volume
2.7M
P/E ratio
-1.75

Palisade Bio, Inc. - Common Stock News

Details

Daily high
$1.97
Daily low
$1.82
Price at open
$1.90
52 Week High
$2.86
52 Week Low
$0.53
Market cap
324.6M
Dividend yield
0.00%
Volume
2.1M
Avg. volume
2.7M
P/E ratio
-1.75